Merck : MRK

All Merck Articles

1084 Articles

Jon C. Ogg | May 8, 2012 at 12:07 PM EDT

The Market Where Defensive Shares Are Working Again (PEP, KO, BUD, TAP, AWK, MCD, KFT, CAG, CPB, HRL, MO, VGR, RAI, PG, KMB, CL, MRK, PFE, JNJ, T, VZ)

Blame whatever you want. A weaker U.S. economy, a weakening and flailing Europe, a move to socialism in France and…

Paul Ausick | Apr 27, 2012 at 4:05 PM EDT

24/7 Wall St. Closing Bell (PM, SNDK, BIDU, AMZN, ALU, ELY, CLWR, DECK, WY, TRP, GT, PG, NWL, MRK, HELE, F, COV, CVX, MDRX, EXPE, WDC)

Markets opened higher this morning following a lower-than-expected GDP growth estimate of 2.2%. That was weaker, but not awful (our…

Jon C. Ogg | Apr 27, 2012 at 9:15 AM EDT

One Big Disbelief of an Amylin Buyout… Worth Only $12 Per Share? (AMLN, BMY, MRK, AZN, SNY, PFE, NVO)

Amylin Pharmaceuticals, Inc. (NASDAQ: AMLN) is supposed to be acquired by a larger drug company. It is one of the…

Jon C. Ogg | Apr 26, 2012 at 11:13 AM EDT

J&J Joins Dividend Hike One-Up Game (JNJ, PFE, MRK)

How many DJIA components can raise their dividend in one week? Johnson & Johnson (NYSE: JNJ) answered that question as…

Jon C. Ogg | Apr 23, 2012 at 2:54 PM EDT

What’s A Better Buyout: Ardea or Amylin? (RDEA, AMLN, AZN, BMY, MRK)

Ardea Biosciences, Inc. (NASDAQ: RDEA) is soaring today on news that AstraZeneca PLC (NYSE: AZN) is paying about $1.26 billion to…

Paul Ausick | Apr 23, 2012 at 7:59 AM EDT

Amylin Seeks a Buyer (AMLN, CS, GS, BMY, SNY, LLY, AZN, MRK)

Diabetes drug maker Amylin Pharmaceuticals Inc. (NASDAQ: AMLN) has hired bankers and lawyers to help the company find a buyer.…

Douglas A. McIntyre | Apr 16, 2012 at 6:34 AM EDT

Media Digest (4/16/2012) Reuters, WSJ, NYT, FT

Concerns about Spain and Italy renew capital markets’ rejection of area debt. (Reuters) Best Buy (NYSE: BBY) will have to…

Paul Ausick | Mar 19, 2012 at 11:11 AM EDT

Biopharma Firm Crushed by Merck Deal Cancellation (CRME, MRK)

Canadian-based drug company Cardiome Pharma Corp. (NASDAQ: CRME) announced this morning that Merck & Co. Inc. (NYSE: MRK) has cancelled…

Paul Ausick | Mar 6, 2012 at 8:55 AM EST

Merck Lowers First Quarter Outlook (MRK)

Drug maker Merck & Co. Inc. (NYSE: MRK) this morning lowered its first quarter non-GAAP EPS estimate to $0.95-$0.98, well…

Paul Ausick | Mar 5, 2012 at 9:40 AM EST

Merck’s Ragweed Allergy Drug Results Good (MRK)

Drug maker Merck & Co. Inc. (NYSE: MRK) has released results of a phase III study of its investigational allergy…

Douglas A. McIntyre | Feb 28, 2012 at 6:11 PM EST

FDA-Use Of Statins May Cause Problems

The FDA announced today that the use of statins, common among people with high cholesterol, pose problems which were not…

Jon C. Ogg | Feb 13, 2012 at 4:17 PM EST

Drug & Biotech Makers Respond Unfavorably To Obama Budget Proposals (AMGN, BIIB, BMY, GSK, JNJ, MRK, PFE)

The Pharmaceutical Research and Manufacturers of America (PhRMA) has spoken out against the new 2013 budget proposed by President Obama. …

Paul Ausick | Feb 6, 2012 at 2:54 PM EST

Merck Will Seek FDA Approval for Insomnia Drug (MRK)

Drug giant Merck & Co. (NYSE: MRK) plans to file this year with the US FDA for approval of the…

Paul Ausick | Feb 2, 2012 at 4:08 PM EST

24/7 Wall St. Closing Bell (DELL, EW, AKS, STLD, BRCM, GMCR, EDMC, NDAQ, QCOM, BZH, BSX, BCO, DO, LEA, MRK, TTWO, VIAB, ZNGA, MNOV, RGDX, BIOS, URG)

All three major US stock indexes opened higher this morning, and spent the rest of the day bouncing around the…

Jon C. Ogg | Feb 2, 2012 at 8:55 AM EST

Merck Close to 52-Week High After Earnings (MRK)

Merck & Company, Inc. (NYSE: MRK) is trading up after its earnings report. With a high dividend yield of 4.4%,…

1 … 57 58 59 60 61 … 73

Merck : MRK

All Merck Articles

The Market Where Defensive Shares Are Working Again (PEP, KO, BUD, TAP, AWK, MCD, KFT, CAG, CPB, HRL, MO, VGR, RAI, PG, KMB, CL, MRK, PFE, JNJ, T, VZ)

24/7 Wall St. Closing Bell (PM, SNDK, BIDU, AMZN, ALU, ELY, CLWR, DECK, WY, TRP, GT, PG, NWL, MRK, HELE, F, COV, CVX, MDRX, EXPE, WDC)

One Big Disbelief of an Amylin Buyout… Worth Only $12 Per Share? (AMLN, BMY, MRK, AZN, SNY, PFE, NVO)

J&J Joins Dividend Hike One-Up Game (JNJ, PFE, MRK)

What’s A Better Buyout: Ardea or Amylin? (RDEA, AMLN, AZN, BMY, MRK)

Amylin Seeks a Buyer (AMLN, CS, GS, BMY, SNY, LLY, AZN, MRK)

Media Digest (4/16/2012) Reuters, WSJ, NYT, FT

Biopharma Firm Crushed by Merck Deal Cancellation (CRME, MRK)

Merck Lowers First Quarter Outlook (MRK)

Merck’s Ragweed Allergy Drug Results Good (MRK)

FDA-Use Of Statins May Cause Problems

Drug & Biotech Makers Respond Unfavorably To Obama Budget Proposals (AMGN, BIIB, BMY, GSK, JNJ, MRK, PFE)

Merck Will Seek FDA Approval for Insomnia Drug (MRK)

24/7 Wall St. Closing Bell (DELL, EW, AKS, STLD, BRCM, GMCR, EDMC, NDAQ, QCOM, BZH, BSX, BCO, DO, LEA, MRK, TTWO, VIAB, ZNGA, MNOV, RGDX, BIOS, URG)

Merck Close to 52-Week High After Earnings (MRK)

Silver and Copper Are Outpacing Gold in 2026 and After Following Industrial Metals These 3 ETFs Show How Smart Money Is Playing the Trend

At 65, Your HSA Stops Being a Medical Account and Starts Beating Your 401(k)

Lower Your Mortgage Payment Without Refinancing, Without Closing Costs, and Without a Credit Check

At 65, Your HSA Stops Being a Medical Account and Starts Beating Your 401(k)

Lower Your Mortgage Payment Without Refinancing, Without Closing Costs, and Without a Credit Check

Silver and Copper Are Outpacing Gold in 2026 and After Following Industrial Metals These 3 ETFs Show How Smart Money Is Playing the Trend

At 65, Your HSA Stops Being a Medical Account and Starts Beating Your 401(k)

Merck : MRK

All Merck Articles

The Market Where Defensive Shares Are Working Again (PEP, KO, BUD, TAP, AWK, MCD, KFT, CAG, CPB, HRL, MO, VGR, RAI, PG, KMB, CL, MRK, PFE, JNJ, T, VZ)

24/7 Wall St. Closing Bell (PM, SNDK, BIDU, AMZN, ALU, ELY, CLWR, DECK, WY, TRP, GT, PG, NWL, MRK, HELE, F, COV, CVX, MDRX, EXPE, WDC)

One Big Disbelief of an Amylin Buyout… Worth Only $12 Per Share? (AMLN, BMY, MRK, AZN, SNY, PFE, NVO)

J&J Joins Dividend Hike One-Up Game (JNJ, PFE, MRK)

What’s A Better Buyout: Ardea or Amylin? (RDEA, AMLN, AZN, BMY, MRK)

Amylin Seeks a Buyer (AMLN, CS, GS, BMY, SNY, LLY, AZN, MRK)

Media Digest (4/16/2012) Reuters, WSJ, NYT, FT

Biopharma Firm Crushed by Merck Deal Cancellation (CRME, MRK)

Merck Lowers First Quarter Outlook (MRK)

Merck’s Ragweed Allergy Drug Results Good (MRK)

FDA-Use Of Statins May Cause Problems

Drug & Biotech Makers Respond Unfavorably To Obama Budget Proposals (AMGN, BIIB, BMY, GSK, JNJ, MRK, PFE)

Merck Will Seek FDA Approval for Insomnia Drug (MRK)

24/7 Wall St. Closing Bell (DELL, EW, AKS, STLD, BRCM, GMCR, EDMC, NDAQ, QCOM, BZH, BSX, BCO, DO, LEA, MRK, TTWO, VIAB, ZNGA, MNOV, RGDX, BIOS, URG)

Merck Close to 52-Week High After Earnings (MRK)

Silver and Copper Are Outpacing Gold in 2026 and After Following Industrial Metals These 3 ETFs Show How Smart Money Is Playing the Trend

At 65, Your HSA Stops Being a Medical Account and Starts Beating Your 401(k)

Lower Your Mortgage Payment Without Refinancing, Without Closing Costs, and Without a Credit Check

Featured Reads

At 65, Your HSA Stops Being a Medical Account and Starts Beating Your 401(k)

Lower Your Mortgage Payment Without Refinancing, Without Closing Costs, and Without a Credit Check